National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

Tuesday, June 05, 2018

A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator. 

Denver Named a Top 10 City for Digital Health Funding

Thursday, July 06, 2017

Denver made the cut as a top 10 city in the US for digital health funding, with five deals topping $192M total in the first half of 2017. With the mid-year funding now coming in over $6B, 2017 has broken numerous records and we anticipate this to be the biggest year yet as huge deals continue to close. 

Colorado BioScience Association Recognizes 2017 Boettcher Investigators

Tuesday, June 13, 2017

DENVER, June 13, 2017 — The Colorado BioScience Association on Tuesday commended the newest class of Boettcher Investigators and expressed its gratitude to the Boettcher Foundation for its continued support of scientific innovation in Colorado. 

Eximis Surgical Wins $25K MedTech Innovator Value Award

Wednesday, June 07, 2017

San Francisco, June 7, 2017 – MedTech Innovator, the medtech industry’s nonprofit global competition and accelerator, congratulates Eximis Surgical for being selected as its Value Award winner at Wilson Sonsini Goodrich & Rosati’s 25th Annual Medical Device Conference on Friday, June 2. 

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

Monday, June 05, 2017

Rapid Advances in Science Fuel New Era of Medicine Aimed at Fighting Cancer  

Colorado BioScience Association appoints new board leadership

Wednesday, May 24, 2017

Terumo BCT General Counsel Scott Larson named chairman of the board  

Nivalis Therapeutics acquired by Seattle-based Alpine Immune Systems

Tuesday, April 18, 2017

A Seattle biotech company is acquiring Boulder’s Nivalis Therapeutics, merging with it to become publicly traded and use Nivalis’ $44 million in cash to fund new immunotherapy cancer and inflammatory disease treatments. 

CU Boulder Study: Federally-Funded Laboratories and Institutions Have a $2.6 Billion Annual Impact in Colorado

Thursday, March 23, 2017

CU Boulder Study: Federally-Funded Laboratories and Institutions Have a $2.6 Billion Annual Impact in Colorado  

Health-Tech Innovators Advocate For Colorado’s Advanced Industries Grants

Tuesday, February 21, 2017

DENVER, Colo. – A culture of collaboration has made Colorado the #1 Health Innovation ecosystem in the United States today.

Organizations like Prime Health, the Colorado Bioscience Association (CBSA), Innosphere and the Office of Economic Development and International Trade (OEDIT), are working on behalf of the ecosystem to support programs and funding that drive innovation and acceleration commercialization.

One of the qualities that make Colorado unique for entrepreneurs is the publicly supported advanced industries grants and tax credits run by OEDIT. These programs encourage private investors to provide funding for local companies with high growth potential.

Full story at CyberMed News

Continue Reading

Boomtown Accelerator forges relationship with Colorado BioScience Association

Wednesday, January 11, 2017

BOULDER, Colo — Jan. 10, 2017 — Boomtown, a startup accelerator that nurtures selected startups through a 12-week mentoring program, is excited to announce that they have established a relationship with the Colorado BioScience Association (CBSA).